Abstract

Scedosporium aurantiacum is an opportunistic filamentous fungus increasingly isolated from the sputum of cystic fibrosis patients, and is especially prevalent in Australia. At the moment, very little is known about the infection mechanism of this fungus. Secreted proteases have been shown to contribute to fungal virulence in several studies with other fungi. Here we have compared the profiles of proteases secreted by a clinical isolate Scedosporium aurantiacum (WM 06.482) and an environmental strain (WM 10.136) grown on a synthetic cystic fibrosis sputum medium supplemented with casein or mucin. Protease activity was assessed using class-specific substrates and inhibitors. Subtilisin-like and trypsin-like serine protease activity was detected in all cultures. The greatest difference in the secretion of proteases between the two strains occurred in mucin-supplemented medium, where the activities of the elastase-like, trypsin-like and aspartic proteases were, overall, 2.5–75 fold higher in the clinical strain compared to the environmental strain. Proteases secreted by the two strains in the mucin-supplemented medium were further analyzed by mass spectrometry. Six homologs of fungal proteases were identified from the clinical strain and five from the environmental strain. Of these, three were common for both strains including a subtilisin peptidase, a putative leucine aminopeptidase and a PA-SaNapH-like protease. Trypsin-like protease was identified by mass spectrometry only in the clinical isolate even though trypsin-like activity was present in all cultures. In contrast, high elastase-like activity was measured in the culture supernatant of the clinical strain but could not be identified by mass spectrometry searching against other fungi in the NCBI database. Future availability of an annotated genome will help finalise identification of the S. aurantiacum proteases.

Highlights

  • Members of Scedosporium spp. are ubiquitous in nature and can be isolated from a wide range of human-impacted environments [1, 2]

  • The clinical isolate S. aurantiacum WM 06.482 and the environmental strain WM 10.136 were cultured in the SCFM medium with addition of casein or mucin to boost growth and induce protease production

  • We have studied a clinical isolate S. aurantiacum WM 06.428 and an environmental isolate WM 10.136 with a view of establishing the profile of proteases secreted by these strains and detecting potential differences in protease production related to their lifestyle

Read more

Summary

Introduction

Members of Scedosporium spp. are ubiquitous in nature and can be isolated from a wide range of human-impacted environments [1, 2]. Some species of the Scedosporium spp. complex such as the recently identified S. aurantiacum are opportunistic pathogens that affect people with diabetes, solid tumours, chronic lung diseases and stem cell transplants [3]. In Australia, S. aurantiacum is the second most common filamentous fungus isolated from the sputum of cystic fibrosis (CF) patients after Aspergillus fumigatus [4, 5]. We have reported phenotypic profiling of this fungus that revealed differences in the carbon substrate utilisation patterns between clinical and environmental S. aurantiacum isolates [13]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call